I. Murray-Lyon

E. Brown, I. Murray-Lyon, P. Gower, 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Extrahepatic Portal Hypertension Protein C Deficiency and Tuberous Sclerosis

I. Murray-Lyon, K. Reynolds, D. Samson, 1991, Journal of the Royal Society of Medicine.

Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.

D. Vergani, G. Mieli-Vergani, A. Eddleston, 1982, Gut.

Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.

G. Alexander, I. Murray-Lyon, T. Harrison, 1987, Gut.

Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.

G. Alexander, I. Murray-Lyon, T. Harrison, 1987, Journal of hepatology.

The HBe antigen‐antibody system and its relationship to clinical and laboratory findings in 100 chronic HBsAg carriers in great britain

I. Murray-Lyon, F. Paradinas, I. Barrison, 1981, Journal of medical virology.

LIVER DISEASE AMONG HOMOSEXUAL MALES

P. Keeling, I. Murray-Lyon, J. Banatvala, 1979, The Lancet.

Management of chronic hepatitis C: clinical audit of biopsy based management algorithm

H. Thomas, R. Goldin, I. Murray-Lyon, 1997 .

Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers

I. Murray-Lyon, R. Shidrawi, R. Dayton, 2004, Journal of medical virology.

Automatic equilibration of volume in exchange transfusion in adults.

I. Murray-Lyon, B. W. Lassers, J. Cash, 1967, Lancet.

The effect of chewing Khat leaves on human mood.

I. Murray-Lyon, A. A. Gunaid, N. Hassan, 2002, Saudi medical journal.

PLASMA AND BRAIN TRYPTOPHAN CHANGES IN EXPERIMENTAL ACUTE HEPATIC FAILURE

R. Williams, I. Murray-Lyon, G. Curzon, 1973, Journal of neurochemistry.

Liver transplantation in man. The significance, patterns, and control of infection

W. D. Foster, I. Murray-Lyon, D. Evans, 1970, The British journal of surgery.

Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy

R. Williams, I. Murray-Lyon, G. Curzon, 1976, European journal of clinical investigation.

Bullous lesions of the skin and mucous membranes in primary amyloidosis

J. Pickard, J. Northover, I. Murray-Lyon, 1972, Postgraduate medical journal.

Reversible plane xanthoma, vasculitis, and peliosis hepatis in giant lymph node hyperplasia (Castleman's disease): a case report and review of the cutaneous manifestations of giant lymph node hyperplasia.

B. Ramsay, D. Woodrow, I. Murray-Lyon, 1992, Journal of the American Academy of Dermatology.

Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosteronetherapy: possible relationships of these changes to the development of peliosis hepatis and liver tumours

I. Murray-Lyon, D. Westaby, F. Paradinas, 1977, Histopathology.

Reversal of liver damage due to long term methyltestosterone and safety of non-17 alpha-alkylated androgens.

I. Murray-Lyon, C. Lowdell, 1985, British medical journal.

Controlled trial of cysteamine and dimercaprol after paracetamol overdose.

J. R. Bennet, B. Gazzard, R. Hughes, 1977, British medical journal.

Intrinsic-factor secretion in response to pentagastrin.

I. Murray-Lyon, N. Finlayson, D. Shearman, 1967, Lancet.

Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion.

B. Gazzard, R. Williams, I. Murray-Lyon, 1976, Gut.

PLATELET ASSOCIATED IMMUNOGLOBULINS IN CHRONIC LIVER DISEASE

I. Murray-Lyon, I. Barrison, I. Knight, 1981, British journal of haematology.

Altered natural history of hepatitis B in homosexual males–‐a reflection of altered immune responsiveness?

I. Murray-Lyon, A. Eddleston, M. G. Anderson, 1985, Journal of medical virology.

Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma.

I. Murray-Lyon, P. Johnson, R. Williams, 1978, Gut.

High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.

B. Portmann, I. Murray-Lyon, P. Johnson, 1982, British medical journal.

Chronic liver disease: the detection and characterization of circulating immune complexes.

C R Howard, I. Murray-Lyon, C. Howard, 1983, Immunology.

Metabolic basis for high paracetamol dosage without hepatic injury: a case study

J. Tredger, P. Thuluvath, I. Murray-Lyon, 1995, Human & experimental toxicology.

Quantitative immunoelectrophoresis of plasma proteins in acute viral hepatitis, extrahepatic biliary obstruction, primary biliary cirrhosis and idiopathic haemochromatosis.

I. Murray-Lyon, R. Williams, 1974, Clinica chimica acta; international journal of clinical chemistry.

Quantitative immunoelectrophoresis of serum proteins in cryptogenic cirrhosis, alcoholic cirrhosis and active chronic hepatitis.

H. G. Clarke, K. McPherson, I. Murray-Lyon, 1972, Clinica chimica acta; international journal of clinical chemistry.

Synthesis of plasma haemopexin, albumin and fibrinogen by the regenerating rat liver.

I. Murray-Lyon, U. Muller-eberhard, H. Liem, 1975, British journal of experimental pathology.

The influence of ammonia and octanoic acid on liver regeneration in the rat.

I. Murray-Lyon, W. Ellis, P. Chu, 1979, Clinical science.

Plasma amino acids in experimental acute hepatic failure and their relationship to brain tryptophan.

R. Williams, I. Murray-Lyon, G. Curzon, 1974, Clinical science and molecular medicine.

A placebo‐controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection

R. Tedder, I. Murray-Lyon, J. Toole, 1999, Journal of viral hepatitis.

Placebo-controlled phase I/II study of adefovir dipivoxil (bis-POM PMEA) in patients with chronic hepatitis B infection.

R. Tedder, I. Murray-Lyon, M. Nelson, 1996 .

Extended treatment with adefovir dipivoxil in patients with chronic hepatitis B virus infection.

R. Tedder, I. Murray-Lyon, H. Jaffe, 1998 .

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.

H. Thomas, I. Murray-Lyon, J. Main, 1989, BMJ.

Prevention of chronic hepatitis B and antiviral therapy

I. Murray-Lyon, M. G. Anderson, 1986 .

Safety of alcohol after viral hepatitis

I. Murray-Lyon, N. Tozun, M. G. Anderson, 1991, The Lancet.

Strategies for hepatitis B immunisation.

I. Murray-Lyon, A. Catterall, A. Catterall, 1992, Gut.

The clinical course of acute type A hepatitis in chronic HBsAg carriers—a report of 3 cases

I. Murray-Lyon, J. Coleman, I. Barrison, 1982, Postgraduate medical journal.

Trial of (+)-Cyanidanol-3 in Patients with Hepatitis B Chronic Liver Disease

R. P. Thompson, J. Macartney, P. Keeling, 1986, Journal of the Royal Society of Medicine.

Suramin treatment for chronic active hepatitis B—toxic and ineffective

A. Zuckerman, I. Murray-Lyon, K. Tsiquaye, 1987, Journal of medical virology.

Prevalence of hepatitis B, C, and D virus markers in yemeni patients with chronic liver disease

I. Murray-Lyon, A. A. Gunaid, J. Coleman, 1993, Journal of medical virology.

Strategies for preventing hepatitis B.

I. Murray-Lyon, 1989, The Quarterly journal of medicine.

Acute sporadic hepatitis in the Republic of Yemen

I. Murray-Lyon, A. A. Gunaid, M. Hill, 1997, Journal of medical virology.

Pre‐S proteins in hepatitis b

A. Zuckerman, H. Thomas, A. Zanetti, 1989, Journal of medical virology.

It's a woman's world - fathers' participation in smoking and drinking reduction in pregnancy

I. Murray-Lyon, E. Waterson, C. Evans, 1988 .

Preventing alcohol related birth damage: a review.

I. Murray-Lyon, E. Waterson, Iain M. Murray-Lyon, 1990, Social science & medicine.

ALCOHOL CONSUMPTION, PREGNANCY, AND LOW BIRTHWEIGHT

I. Murray-Lyon, K. Macrae, I. Barrison, 1983, The Lancet.

Preventing fetal alcohol effects; a trial of three methods of giving information in the antenatal clinic

I. Murray-Lyon, E. Waterson, 1990 .

Drinking and smoking patterns amongst women attending an antenatal clinic--II. During pregnancy.

I. Murray-Lyon, E. Waterson, 1989, Alcohol and alcoholism.

Alcohol consumption and the risk of first trimester miscarriage

I. Murray-Lyon, K. Macrae, E. Waterson, 1994 .

Intestinal capillariasis acquired in Egypt.

P. Chiodini, I. Murray-Lyon, M. Mikhail, 1999, European journal of gastroenterology & hepatology.

The Effect of Qat Chewing on Blood Pressure and Heart Rate in Healthy Volunteers

I. Murray-Lyon, N. Hassan, A. A. Gunaid, 2000, Tropical doctor.

Bowel preparation at home: prospective study of adverse effects in elderly people

I. Murray-Lyon, L. Coulter, T. Heymann, 1996, BMJ.

Liver Transplantation in Man—III, Studies of Liver Function, Histology, and Immunosuppressive Therapy

Roger Williams, A. Eddleston, I. Murray-Lyon, 1969 .

Kinetics of [14C]cholic acid in fulminant hepatic failure: a prognostic test.

I. Murray-Lyon, R. Williams, E. Schuster, 1976, Gastroenterology.

Hepatic scintiscanning in fulminant hepatic failure.

R. Williams, I. Murray-Lyon, A. R. Davidson, 1973, The British journal of radiology.

Khat chewing and arterial blood pressure. A randomized controlled clinical trial of alpha-1 and selective beta-1 adrenoceptor blockade.

I. Murray-Lyon, A. A. Gunaid, N. Hassan, 2005, Saudi medical journal.

Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk.).

I. Murray-Lyon, J. Halket, Z. Karasu, 1995, Journal of ethnopharmacology.

Khat chewing and bladder neck dysfunction. A randomized controlled trial of alpha 1-adrenergic blockade.

I. Murray-Lyon, J. Ramsay, A. Qirbi, 1995, British journal of urology.

The subjective effects of chewing Qat leaves in human volunteers.

I. Murray-Lyon, A. A. Gunaid, F. M. E. El Khally, 2002, Annals of Saudi medicine.

Vancomycin in resistant hepatic encephalopathy.

I. Murray-Lyon, A. Forbes, 1990, Gut.

Non-obstructive dilatation of the intrahepatic biliary tree with cholangitis.

I. Murray-Lyon, R. Williams, K. Shilkin, 1972, The Quarterly journal of medicine.

Improved liver-biopsy needle.

I. Murray-Lyon, R. Williams, I. Ansell, 1969, Lancet.

Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs.

L. Blendis, I. Murray-Lyon, J. Dawson, 1970, Lancet.

Congenital hepatic fibrosis--is it a single clinical entity?

I. Murray-Lyon, R. Williams, B. G. Ockenden, 1973, Gastroenterology.

Clinical and Electroencephalographic Assessment of Diazepam in Liver Disease

R. Knill-Jones, R. Williams, I. Murray-Lyon, 1971, British medical journal.

Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study.

A. Lok, H. Thomas, I. Murray-Lyon, 1985, Journal of hepatology.

Hazardous and harmful drinking: a comparison of the AUDIT and CAGE screening questionnaires.

I. Murray-Lyon, I M Murray-Lyon, M T McCusker, 2002, QJM : monthly journal of the Association of Physicians.

Asking about alcohol: a comparison of three methods used in an antenatal clinic

I. Murray-Lyon, E. Waterson, 1988 .

Khat (Catha edulis): health aspects of khat chewing.

I. Murray-Lyon, A. A. Gunaid, N. Hassan, 2007, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

Diseases of the alimentary system. Jaundice.

I. Murray-Lyon, K. Reynolds, 1976, British medical journal.

Khat chewing delays gastric emptying of a semi‐solid meal

I. Murray-Lyon, J. Bomanji, C. Drinkwater, 1995, Alimentary pharmacology & therapeutics.

Hepatic complications of androgen therapy.

I. Murray-Lyon, D. Westaby, F. Paradinas, 1977, Gastroenterology.

Oesophageal function in cirrhotic patients undergoing injection sclerotherapy for oesophageal varices.

R. Bailey, I. Murray-Lyon, R. Williams, 1978, Digestion.

Hepatic abscesses complicating injection sclerotherapy of haemorrhoids.

I. Murray-Lyon, J. Kirkham, 2001, European journal of gastroenterology & hepatology.

Controlled trial of corticosteroids and azathioprine in active chronic hepatitis.

R. Stern, I. Murray-Lyon, R. Williams, 1973, Gut.

Budd-Chiari Syndrome in Association with Polycystic Disease of the Liver and Kidneys

I. Murray-Lyon, D. Samson, K. Talbot, 1992, Journal of the Royal Society of Medicine.

Preconception clinics.

I. Murray-Lyon, I. Barrison, J. Wright, 1981, British medical journal.

Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy

B. Portmann, Roger Williams, I. Murray-Lyon, 2010, European journal of gastroenterology & hepatology.

Cortical and optic atrophy following fulminant hepatic failure.

I. Murray-Lyon, J. Parkes, R. Williams, 1977, Medecine & chirurgie digestives.

Bone disease after jejuno-ileal bypass for morbid obesity.

I. Murray-Lyon, S. Fenton, J. Eastwood, 1983, Postgraduate medical journal.

Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen

I. Murray-Lyon, A. A. Gunaid, N. Hassan, 2004, European journal of gastroenterology & hepatology.

Prevalence and risk factors for Helicobacter pylori infection among Yemeni dyspeptic patients.

I. Murray-Lyon, N. Hassan, A. A. Gunaid, 2003, Saudi medical journal.

Modulation of cholinergic contraction by cathinone: beneficial effects in airway diseases

M. Belvisi, I. Murray-Lyon, M. Birrell, 2015 .

Modulation of cholinergic contractions of airway smooth muscle by cathinone: potential beneficial effects in airway diseases

M. Belvisi, I. Murray-Lyon, M. Birrell, 2008, European Respiratory Journal.

Chewing Qat leaves slows the whole gut transit time.

I. Murray-Lyon, A. A. Gunaid, N. A. Hassan, 1999, Saudi medical journal.

Blood base changes after secretion of bicarbonate by pancreas.

I. Murray-Lyon, N. Finlayson, D. Shearman, 1968, British medical journal.

Adverse effects of alcohol in pregnancy.

I. Murray-Lyon, I. Barrison, E. Waterson, 1985, British journal of addiction.

Alcohol and foetal damage.

I. Murray-Lyon, 1985, Alcohol and Alcoholism.

Complication of mebendazole treatment for hydatid disease.

I. Murray-Lyon, K. Reynolds, 1979, British medical journal.

Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy – patients’ views of early cessation of therapy

W. Rosenberg, I. Murray-Lyon, G. Foster, 2005, Alimentary pharmacology & therapeutics.

Hepatitis C in a renal dialysis centre

E. Brown, I. Murray-Lyon, J. Boultbee, 1991 .

Serum Proteins after a Liver Transplant

H. G. Clarke, Roger Williams, I. Murray-Lyon, 1971, Nature.

Imported epidemic non‐A, non‐B hepatitis in Qatar

A. Zuckerman, I. Murray-Lyon, C. Howard, 1985, Journal of Medical Virology.

Ethnic differences in the consequences of alcohol misuse.

I. Murray-Lyon, H. Romaniuk, D. Marjot, 1990, Alcohol and alcoholism.

CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis

S. Shousha, I. Murray-Lyon, D. Bansi, 2004, Histopathology.

CHOLANGIOCARCINOMA AND ORAL CONTRACEPTIVES

I. Murray-Lyon, E. Littlewood, F. Paradinas, 1980, The Lancet.

Histological sexing of a reticulum cell sarcoma arising after liver transplantation.

I. Murray-Lyon, R. Williams, B. Portmann, 1976, Gastroenterology.

Helicobacter pylori and intestinal metaplasia: comparison between British and Yemeni patients.

S. Shousha, I. Murray-Lyon, A. Arnaout, 1993, The American journal of gastroenterology.

Interferon-α therapy with and without interferon-α priming in patients with chronic hepatitis B infection

J. Lau, H. Daniels, R. Williams, 1993 .

Haemangiomatosis of the small and large bowel with histological malignant change

I. Murray-Lyon, N. Porter, Iain M. Murray‐Lyon, 1971, The Journal of pathology.

The Use of Cysteamine and Dimercaprol

B. Gazzard, R. Hughes, I. Murray-Lyon, 1976, Journal of International Medical Research.

SURGICAL TRANSMISSION OF HEPATITIS A

I. Murray-Lyon, G. Williams, 1981, The Lancet.

SENSE WITH SENGSTAKENS

I. Murray-Lyon, A. Johnson, K. Reynolds, 1976, The Lancet.

Post‐hepatitis syndrome revisited

I. Murray-Lyon, A. Burgess, D. Wright, 1995, Journal of viral hepatitis.

Transplantation of the liver in man.

A. Eddleston, I. Murray-Lyon, Martin Smith, 1970, British medical journal.

Management of chronic hepatitis C: clinical audit of biopsy based management algorithm

R. Goldin, I. Murray-Lyon, G. Foster, 1997, BMJ.

Studies on plasma proteins in liver disease using quantitative immunoelectrophoresis

I. Murray-Lyon, 1973 .

Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.

D. Vergani, G. Mieli-Vergani, A. Eddleston, 1982, Gut.

Sarcoidosis presenting as multiple subcutaneous nodules

I. Murray-Lyon, R. Shidrawi, F. Paradinas, 1994, Clinical and experimental dermatology.

The assay of microsomal epoxide hydrolase in normal and pathological human liver.

C. Walker, I. Murray-Lyon, A. Craven, 1982, Biochemical pharmacology.

Southern hybridisation analysis of HBV DNA in peripheral blood leucocytes and of different cell types: Changes during the natural history and with interferon‐α therapy in patients with hepatitis B virus infection

A. Zuckerman, I. Murray-Lyon, T. Harrison, 1994, Journal of medical virology.

ALCOHOL ABUSE IN PREGNANCY: A PROBLEM IN LONDON

I. Murray-Lyon, I. Barrison, J. Wright, 1980, The Lancet.

Drinking and smoking patterns amongst women attending an antenatal clinic--I. Before pregnancy.

I. Murray-Lyon, E. Waterson, 1989, Alcohol and alcoholism.